In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.
Commentary|Podcasts|February 9, 2026
Pharma Pulse: TrumpRx Takes Flight and Novo Nordisk’s Super Bowl Gambit
Author(s)Nicholas Saraceno, Senior Editor
In today’s Pharma Pulse, TrumpRx officially goes live, while Novo Nordisk prepares to take the oral version of Wegovy to the biggest stage in advertising.
Advertisement
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
- The Trump administration has officially launched
TrumpRx , a program centered on the most-favored nation pricing model. The platform offers MFN-aligned discounts via coupons for brand-name drugs, with 43 products listed and expansion anticipated across various categories, including fertility and anti-obesity GLP-1 therapies. - Meanwhile, Novo Nordisk is making history. The Danish giant has secured its
first-ever Super Bowl ad to promote the oral version of Wegovy, and is looking to dominate the metabolic market by highlighting the convenience of a pill over an injection. The commercial released on the morning of Feb. 6 uses both humor and celebrity appearances to challenge the notion that weight-loss medications represent “the easy way out.”
That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit
Thanks for listening—until next time, stay well and stay informed.
You can catch Pharma Pulse directly on
Advertisement
Related to this article
In this week's Pharma Pulse, DHL adds six dedicated cold chain air corridors linking Europe and North America to Asia, Walmart rolls out a $0 prescription tier and rare disease Center of Excellence for its US workforce and FDA launches its Rare Disease Framework Initiative.
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
PhRMA's lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.
Epic's Prescription Marketplace, due summer 2027, will show pharmacy cash prices next to insured costs before a prescription is sent.
Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke.
FDA’s final guidance on prescription drug use-related software clarifies when companion app content is labeling, promotion or belongs in the PI.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion
2
Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers
3
How Pharma Automation Cuts Human Touches and Error Risk
4
FAQ: How Is AI Being Deployed in Pharma Supply Chains?
5